Clinical Evaluation of an Investigational Blood Creatinine Point-of-Care Test Device
Observational Model: Cohort, Time Perspective: Prospective
The primary outcomes would be, reduced wait time and increased patient satisfaction.
conclusion of the study
Martin Fleisher, PhD
Memorial Sloan-Kettering Cancer Center
United States: Institutional Review Board
|Memorial Sloan Kettering Cancer Center||New York, New York 10021|